Renub

    Anti-Snoring Devices Market Report by Products (Oral Appliances, Nasal Devices, Tongue-Stabilizing Devices, Chin Straps, Position Control Devices, Expiratory Positive Airway Pressure (EPAP) Therapy Devices), Distribution Channels (Retail Pharmacies, Online Stores), End-Users (Homecare, Others), Regions and Company Analysis 2024-2032

    Excel: 8 Hours
    PDF: 24 Hours
    Apr 2024
    Pages: 180

    Anti-Snoring Devices Market Outlook

    Global Anti-Snoring Devices Market is expected to be priced at US$ 3.11 Billion by 2032, compared to US$ 1.55 Billion in 2023 according to Renub Research. It is anticipated to develop at a CAGR of 8.04% between 2024 and 2032.

    Anti-snoring devices have received a reputation in regular life due to their effectiveness in addressing a common sleep difficulty affecting individuals and their partners. With snoring often causing disruptions in sleep quality and leading to daytime fatigue, those gadgets offer a non-invasive solution to improve sleep hygiene. Their convenience, affordability, and non-surgical nature make them handy to many searching for remedies for snoring. As recognition of the health implications of loud snoring grows, more people are turning to those gadgets as a practical way to mitigate its outcomes and enhance ordinary sleep quality.


    Global Anti Snoring Devices Market Trends

    Increased consciousness about the fitness implications of snoring and sleep apnea drives the global anti snoring devices market. Snoring can result in disrupted sleep styles, daytime fatigue, and a higher chance of developing cardiovascular diseases, high blood pressure, and different health troubles. As human beings become more aware of possible dangers, they seek solutions to improve their sleep quality, propelling the demand for anti-snoring devices and surgical interventions.

    Moreover, the escalating incidence of snoring and sleep issues like obstructive sleep apnea (OSA) propels the global anti-snoring devices market. OSA, characterized by recurrent upper airway blockage at some stage in sleep, results in snoring and respiratory interruptions. The Sleep Foundation predicted sleep problems afflict 50-70 million Americans. As a result, there's a growing demand for practical anti-snoring gadgets, such as non-stop advantageous airway strain (CPAP) machines and mandibular development gadgets (MADs), to control obstructive sleep apnea (OSA) and relieve snoring. This increasing prevalence of sleep apnea underscores the want for efficient answers, driving the increase of the anti-snoring devices market.

    People stricken by weight problems may additionally suffer from snoring issues and sleep apnea because of the neck fat present. Lying down causes the upper airway to constrict, increasing snoring possibilities. Thus, the growing incidence of obesity because of terrible eating habits by some of the populace drives the global anti-snoring devices market to improve. As cognizance of the health risks related to snoring and sleep apnea is growing, more individuals are seeking scientific assistance and getting diagnosed.

    The anti-snoring devices market is expected to grow, driven by developed countries, which include the U.S., Canada, and Germany. This is because of the growing prevalence of snoring in those countries, the adoption of advanced anti-loud snoring devices, and the easy accessibility of those devices. Additionally, the healthcare industry in rising economies is developing extensively, thanks to the emergence of recent clinical devices and an upward demand for more suitable healthcare services. Furthermore, the senior population is growing and more susceptible to loud snoring, leading to a better market for anti-snoring devices.


    Oral devices are believed to be essential anti-snoring products in the global market

    Oral devices are considered significant products in the global anti-snoring devices market. This is attributed to their effectiveness and non-invasiveness. These gadgets, also known as mandibular advancement devices (MADs) or mandibular repositioning devices (MRDs), work by moving the lower jaw ahead at some stage in sleep, stopping airway collapse and lessening snoring. With growing consciousness about the unfavorable health outcomes of snoring and the increasing preference for non-surgical solutions, oral gadgets have won recognition amongst people searching for convenient and secure options to alleviate snoring and improve sleep.


    United States has taken the lead in the global anti-snoring devices market

    The United States emerged as the leading segment of the global anti-snoring devices market, securing the best sales share. This dominance may be attributed to the considerable occurrence of snoring among people inside the U.S.

    According to a 2022 document from John Hopkins University, approximately 45.0% of adults snore occasionally, while 25.0% snore often. A key contributor to the growing prevalence of loud snoring within the region is the increasing obesity rates, specifically in the U.S., driven by sedentary existence and higher consumption of processed ingredients. The presence of established market gamers and the accessibility of merchandise through e-commerce structures and retail outlets are anticipated to force market penetration and make more considerable product outreach.


    Retail pharmacies are positioned to secure the most significant portion of the global anti-snoring devices market

    Retail pharmacies are poised to claim the most significant percentage of the global anti-snoring devices market. This is owed to their vast accessibility and convenience for customers. Retail pharmacies are key distribution channels for these products, with the rising demand for over-the-counter answers to cope with snoring problems. Moreover, the capacity to offer personalized suggestions and steerage from healthcare specialists in retail pharmacy settings complements consumer confidence. It promotes the adoption of anti-snoring devices, contributing to their anticipated dominance in the market.


    Homecare solutions are expected to dominate the global anti-snoring devices market

    Homecare is predicted to dominate the global anti-snoring devices market. This is due to the increasing choice for non-invasive and convenient answers to snoring. As more individuals seek practical approaches to manage snoring from the comfort of their houses, the call for over-the-counter anti-snoring gadgets is projected to surge. Further, technological improvements have developed user-friendly and low-priced homecare devices, propelling their adoption and contributing to their significant percentage in the anti-snoring devices market.


    Anti-Snoring Devices Companies Market News

    Koninklijke Philips N.V., ResMed, Inc., SomnoMed Limited, GSK Plc, Apnea Sciences Corporation, ZQuiet (Sleeping Well, LLC), Airway Management, Inc., Fisher & Paykel Healthcare Limited., and Tomed GmbH are the major players in the global anti-snoring devices market.

    • In July 2022 - Glidewell introduced a new product to its range of mandibular advancement devices, namely, the Silent Nite Sleep Appliance featuring the Glidewell Hinge. This device is designed to address both snoring and obstructive sleep apnea (OSA).


    By Products –

    1.    Oral Appliances
    2.    Nasal Devices
    3.    Tongue-Stabilizing Devices
    4.    Chin Straps
    5.    Position Control Devices
    6.    Expiratory Positive Airway Pressure (EPAP) Therapy Devices


    By Distribution Channels –

    1.    Retail Pharmacies
    2.    Online Stores


    By End-Users –

    1.    Homecare
    2.    Others


    By Country –

    1.    North America

    1.1    United States
    1.2    Canada

    2.    Europe

    2.1    France
    2.2    Germany
    2.3    Italy
    2.4    Spain
    2.5    United Kingdom
    2.6    Belgium
    2.7    Netherlands
    2.8    Turkey

    3.    Asia Pacific

    3.1    China
    3.2    Japan
    3.3    India
    3.4    South Korea
    3.5    Thailand
    3.6    Malaysia
    3.7    Indonesia
    3.8    Australia
    3.9    New Zealand

    4.    Latin America

    4.1    Brazil
    4.2    Mexico
    4.3    Argentina

    5.    Middle East & Africa

    5.1    Saudi Arabia
    5.2    UAE
    5.3    South Africa


    All the Key players have been covered from 3 Viewpoints:

    •    Overview
    •    Recent Development
    •    Revenue Analysis


    Company Analysis:

    1.    Koninklijke Philips N.V.
    2.    ResMed, Inc.
    3.    SomnoMed Limited
    4.    GSK Plc
    5.    Apnea Sciences Corporation
    6.    ZQuiet (Sleeping Well, LLC)
    7.    Airway Management, Inc.
    8.    Fisher & Paykel Healthcare Limited.
    9.    Tomed GmbH


    Report Details:

    Report Features Details
    Base Year 2023
    Historical Period 2019 – 2023
    Forecast Period 2024 – 2032
    Market US$ Billion
    Segment Covered Product, Distribution Channel, End User, and Countries
    Countries Covered United States, Canada, France, Germany, Italy, Spain, United Kingdom, Belgium, Netherlands, Turkey, China, Japan, India, South Korea, Thailand, Malaysia, Indonesia, Australia, New Zealand, Brazil, Mexico, Argentina, Saudi Arabia, UAE, and South Africa
    Companies Covered Koninklijke Philips N.V., ResMed, Inc., SomnoMed Limited, GSK Plc, Apnea Sciences Corporation, ZQuiet (Sleeping Well, LLC), Airway Management, Inc., Fisher & Paykel Healthcare Limited., and Tomed GmbH
    Customization Scope 20% Free Customization
    Post-Sale Analyst Support 1 Year (52 Weeks)
    Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request)

    1.    Introduction

    2.    Research Methodology

    3.    Executive Summary

    4.    Market Dynamics

    4.1    Growth Drivers
    4.2    Challenges


    5.    Global Anti-Snoring Devices Market

    6.    Market Share –

    6.1    Product
    6.2    Distribution Channel
    6.3    End Users
    6.4    Country


    7.    Product –

    7.1    Oral Appliances
    7.2    Nasal Devices
    7.3    Tongue-Stabilizing Devices
    7.4    Chin Straps
    7.5    Position Control Devices
    7.6    Expiratory Positive Airway Pressure (EPAP) Therapy Devices


    8.    Distribution Channel –

    8.1    Retail Pharmacies
    8.2    Online Stores


    9.    End Users –

    9.1    Homecare
    9.2    Others


    10.    Country –

    10.1    North America

    10.1.1    United States
    10.1.2    Canada

    10.2    Europe

    10.2.1    France
    10.2.2    Germany
    10.2.3    Italy
    10.2.4    Spain
    10.2.5    United Kingdom
    10.2.6    Belgium
    10.2.7    Netherlands
    10.2.8    Turkey

    10.3    Asia Pacific

    10.3.1    China
    10.3.2    Japan
    10.3.3    India
    10.3.4    South Korea
    10.3.5    Thailand
    10.3.6    Malaysia
    10.3.7    Indonesia
    10.3.8    Australia
    10.3.9    New Zealand

    10.4    Latin America

    10.4.1    Brazil
    10.4.2    Mexico
    10.4.3    Argentina

    10.5    Middle East & Africa

    10.5.1    Saudi Arabia
    10.5.2    UAE
    10.5.3    South Africa


    11.    Porter’s Five Analysis –

    11.1    Bargaining Power of Buyers
    11.2    Bargaining Power of Suppliers
    11.3    Degree of Rivalry
    11.4    Threat of New Entrants
    11.5    Threat of Substitutes


    12.    SWOT Analysis –

    12.1    Strength
    12.2    Weakness
    12.3    Opportunity
    12.4    Threat


    13.    Key Players

    13.1    Koninklijke Philips N.V.

    13.1.1    Overview
    13.1.2    Recent Development
    13.1.3    Revenue

    13.2    ResMed, Inc.

    13.2.1    Overview
    13.2.2    Recent Development
    13.2.3    Revenue

    13.3    SomnoMed Limited

    13.3.1    Overview
    13.3.2    Recent Development
    13.3.3    Revenue

    13.4    GSK Plc

    13.4.1    Overview
    13.4.2    Recent Development
    13.4.3    Revenue

    13.5    Apnea Sciences Corporation

    13.5.1    Overview
    13.5.2    Recent Development

    13.6    ZQuiet (Sleeping Well, LLC)

    13.6.1    Overview
    13.6.2    Recent Development

    13.7    Airway Management, Inc.

    13.7.1    Overview
    13.7.2    Recent Development

    13.8    Fisher & Paykel Healthcare Limited.

    13.8.1    Overview
    13.8.2    Recent Development

    13.9    Tomed GmbH

    13.9.1    Overview
    13.9.2    Recent Development

    Related Reports